Politics & Business | Page 8 of 9

Diabetes Drug Prescriptions in England Up By 40%

The cost and number of drugs prescribed to treat diabetes in England has risen by more than 40 percent in the last five years, according to a new National Health Service (NHS) report released today. According to Diabetes UK the NHS Information Centre has found that just over 35.5 million prescription items were dispensed in primary care units across England...

Diabetes Costs Out of Control In UK, Researchers Say

Researchers from the University of Cardiff, Wales, have found that the British National Health Service (NHS) costs for diabetes drugs, even taking into account the price of inflation, went up by 104% between 2000 - 2008, the BBC reports. According to the researchers the NHS is spending too much on diabetes drugs that account for 7% of the UK prescribing budget...

Diamyd and Ortho-McNeil-Janssen Pharmaceuticals Agreement Receives Antitrust Clearance

Diamyd Medical AB announced it has received antitrust clearance that closes the transaction announced on June 22, 2010 with Ortho-McNeil-Janssen Pharmaceuticals, Inc. (OMJPI), a Johnson & Johnson company. The US Federal Trade Commission's clearance under the Hart-Scott-Rodino Anti-Trust Improvements Act...

JDRF Testifies Before Congress on Diabetes Research and Need for Renewal of the Special Diabetes Program

According to a Juvenile Diabetes Research Foundation (JDRF) press release, representatives from the JDRF testified this week in two congressional hearings focused on advances in diabetes research and the importance of continued diabetes research funding through the Special Diabetes Program...

Children with Diabetes in California Schools: ADA Issues Statement

The American Diabetes Association (ADA) issued a statement expressing extreme disappointment in the California Court of Appeal ruling in the case of American Nurses Association et al. v. O’Connell, which prevents non-medical school personnel from volunteering to administer insulin to California schoolchildren who are not yet able to self-manage their disease...

Novo Nordisk to Stop Insulin Sales in Greece

Novo Nordisk has decided to stop sales of its insulin product in Greece following a government decree ordering a 25% price cut in all medicines, according to a BBC report. The company, which claims it is owed 32 million dollars by the Greek state, said that such a price cut would force its business in Greece to run at a loss. The company was also concerned that the compulsory 25% reduction would have a knock-on effect since other countries use Greece as a key reference point for setting drug prices...

White House Gives $15.8 Million for Utah Diabetes Program

The White House announced it would grant $15.8 million for a pilot program in Utah designed to help improve management of diabetes, according to a Desert News report.The grant is part of a $220 million stimulus-funded effort to expand use of electronic health records.The grant went to HealthInsight of Salt Lake City...

Fat Epidemic Threat to National Security

According to a group of retired admirals, generals, and other senior military leaders, about 27 percent of young adults are medically ineligible for the military service, CNN reports. The leading medical reason is being overweight or obese. The Army's body fat limit for women in the 21-27 age range, with no prior service is 32 percent body fat and for males...

Could the Food Industry be a Diabetes Advocate?

Diabetics want good taste just like everyone else, and more precise labeling information without all the quarter-cup-per-serving gibberish...

Roche Expands Diabetes Portfolio

Roche announced the acquisition of Medingo Ltd., a company engaged in the development of a semi-disposable insulin patch pump. The new Medingo Ltd. micro pump insulin delivery system consists of two parts: a semi-disposable insulin dispensing patch and a remote control, which allows for discreet personalized insulin delivery...